Skip to main content
Book cover

Combating Fungal Infections

Problems and Remedy

  • Book
  • © 2010

Overview

  • Unique as it gives an overall comprehensive holistic
  • approach and recent developments in combating fungal infections
  • Special focus is given to the management of pulmonary mycoses in stem cell transplantation
  • Issues of antifungal drug toxicity are discussed
  • Includes supplementary material: sn.pub/extras

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 chapters)

Keywords

About this book

Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef?cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi?ed and validated.

Editors and Affiliations

  • Fac. Agricultural Sciences, Dept. Agricultural Microbiology, Aligarh Muslim University, Aligarh, India

    Iqbal Ahmad

  • Dept. Biochemistry, Interdiciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India

    Mohammad Owais

  • J. N. Medical College, Dept. Microbiology, Aligarh Muslim University, Aligarh, India

    Mohammed Shahid

  • James Graham Brown Cancer Center, Louisville, USA

    Farrukh Aqil

Bibliographic Information

  • Book Title: Combating Fungal Infections

  • Book Subtitle: Problems and Remedy

  • Editors: Iqbal Ahmad, Mohammad Owais, Mohammed Shahid, Farrukh Aqil

  • DOI: https://doi.org/10.1007/978-3-642-12173-9

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2010

  • Hardcover ISBN: 978-3-642-12172-2Published: 11 August 2010

  • Softcover ISBN: 978-3-642-44672-6Published: 13 December 2014

  • eBook ISBN: 978-3-642-12173-9Published: 03 August 2010

  • Edition Number: 1

  • Number of Pages: XX, 539

  • Topics: Medical Microbiology, Microbiology, Immunology, Pharmacology/Toxicology

Publish with us